Insulin patch pump having photoplethysmography module
A body-worn medication delivery pump having a patch form factor is provided that includes a controller and an integrated plethysmographic module that employs a photoplethysmographic multi-chip package disposed in a skin contact element designed to maintain contact with a wearer's skin during motion, reduce contact pressure inflammation during prolonged contact, reduce crosstalk and ingress of stray light, such that the controller of the pump programmed is programmed to adjust its medication delivery algorithms responsive to outputs of the plethysmographic module.
1 . A medication infusion device comprising:
a flexible adhesive patch configured to be removably attached to a wearer's skin, the flexible adhesive patch having a periphery that defines an opening;
a pump having a pump case with a lower surface configured to contact the periphery of the flexible adhesive patch, the lower surface including a bump configured to extend through the opening, the pump case configured to be removably coupled to the flexible adhesive patch to transcutaneously deliver doses of medication from a replaceable single-use cartridge disposed within the pump case to the wearer; and
a photoplethysmographic module disposed within the bump, the photoplethysmographic module having an LED, a detector, and a skin contact element including at least one transparent window, wherein the LED emits light to, and the detector receives reflected light from, the wearer's skin through the at least one transparent window.
2 . The medication infusion device of claim 1 , wherein the bump protrudes from the pump case and is configured to urge the skin contact element into contact with the wearer's skin during motion.
3 . The medication infusion device of claim 2 , wherein the skin contact element is surrounded by a light-blocking rib.
4 . The medication infusion device of claim 2 , wherein the skin contact element has a substantially elongated rectangular shape and gently sloped sidewalls.
5 . The medication infusion device of claim 1 , wherein the patch pump further comprises a controller programmed to analyze signals output by the photoplethysmographic module to adjust an algorithm that controls delivery of medication to the wearer.
6 . The medication infusion device of claim 5 , wherein the controller is disposed on a main circuit board and the photoplethysmographic module is electrically coupled to the main circuit board by a flex circuit.
7 . The medication infusion device of claim 5 , further comprising an accelerometer disposed within the pump case and electrically coupled to the controller.
8 . The medication infusion device of claim 1 , wherein the pump further comprises a gear system and micro-dosing unit.
9 . The medication infusion device of claim 8 , wherein the micro-dosing unit includes cam-driven levers.
10 . The medication infusion device of claim 1 , wherein the LED and the detector are disposed on a ceramic package and the photoplethysmographic module further comprises a frame that retains the ceramic package at a uniform spacing from the at least one transparent window.
11 . An insulin delivery device comprising:
an adhesive patch configured to be removably attached to a wearer's skin, the adhesive patch having a periphery that defines an opening;
a pump configured to be removably coupled to the adhesive patch to transcutaneously deliver insulin from an on-board replaceable single-use cartridge to the wearer, the pump having a pump case including a lower surface configured to adhere to the periphery of the adhesive patch, the lower surface including a protrusion that extends through the opening; and
a plethysmographic module disposed within the protrusion, the plethysmographic module having an LED, a detector, and a skin contact element including at least one transparent window, wherein the LED emits light to, and the detector receives reflected light from, a skin surface of the wearer via the at least one transparent window.
12 . The insulin delivery device of claim 11 , wherein the protrusion is configured to retain the skin contact element of the plethysmographic module in contact with the skin surface during motion.
13 . The insulin delivery device of claim 12 , wherein the skin contact element is surrounded by a light-blocking rib.
14 . The insulin delivery device of claim 12 , wherein the protrusion has a substantially elongated rectangular shape and gently sloped sidewalls configured to reduce skin inflammation during prolonged contact.
15 . The insulin delivery device of claim 11 , wherein the pump further comprises a controller programmed to analyze signals output by the plethysmographic module to adjust an algorithm controlling delivery of insulin to the wearer.
16 . The insulin delivery device of claim 15 , wherein the controller is disposed on a main circuit board and the plethysmographic module is electrically coupled to the main circuit board by a flex circuit.
17 . The insulin delivery device of claim 15 , further comprising an accelerometer disposed within the pump case and electrically coupled to the controller.
18 . The insulin delivery device of claim 11 , wherein the pump further comprises a gear system and micro-dosing unit.
19 . The insulin delivery device of claim 18 , wherein the micro-dosing unit includes cam-driven levers.
20 . The insulin delivery device of claim 11 , wherein the LED and the detector are disposed on a ceramic package and the plethysmographic module further comprises a frame that retains the ceramic package at a uniform spacing from the at least one transparent window.